Jump to content

Zoetis

From Wikipedia, the free encyclopedia

Zoetis Inc.
TypePublic
IndustryPharmaceutical
Founded1952; 74 years ago (1952)
HeadquartersParsippany, New Jersey, U.S.
Area served
Worldwide
Key people
RevenueIncrease US$9.47 billion (2025)
Increase US$2.67 billion (2025)
Total assetsIncrease US$15.467 billion (2025)
Total equityIncrease US$3.331 billion (2025)
Number of employees
14,500 (2025)
Websitezoetis.com
Footnotes
[1]

Zoetis Inc. (/zō-EH-tis/[2]), headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide.[2] The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products.[1] The company has operations in over 50 countries.[1]

In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock.[1] In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses.[1]

The firm is named Zoetis in allusion to the Greek-derived zoological term zoetic, meaning "pertaining to life".[2] The company was owned by Pfizer until 2013.

History

[edit]

1950s to 2000s

[edit]
Zoetis building in Exton, PA

In the 1950s, Pfizer began research on several drugs, including oxytetracycline, which was found to be effective in livestock.[3]

In 1952, the Pfizer Agriculture Division opened a 732-acre research and development facility in Terre Haute, Indiana, called Vigo.[3]

In 1988, the division was renamed Pfizer Animal Health.[3]

In 1995, Pfizer acquired Norden Laboratories from GlaxoSmithKline for $1.45 billion, expanding its animal health division into small animal care, including pets.[3][4]

Secondary research and development centres were opened in Kalamazoo, Michigan, in 2003.[3]

In April 2003, Pfizer acquired Pharmacia Corporation for $60 billion in stock.[5] Pfizer absorbed its animal health assets, which included the legacy operations of The Upjohn Company, into Pfizer Animal Health.[6]

In December 2006, Pfizer Animal Health acquired Embrex, which provides inoculations for poultry against various diseases, for $155 million.[7]

In March 2008, Pfizer Animal Health acquired Catapult Genetics, a developer of livestock DNA tests and gene markers, and Bovigen, which markets DNA technology.[8]

In April 2008, Pfizer Animal Health acquired vaccine products from Schering-Plough.[9]

In June 2009, Pfizer Animal Health acquired Vetnex Animal Health from ICICI Bank.[10]

In October 2009, Pfizer acquired Wyeth, including its subsidiary Fort Dodge Animal Health, which was added to Pfizer Animal Health.[11] Some assets were sold to Boehringer Ingelheim to gain regulatory approval for the transaction.[12]

In May 2010, Pfizer Animal Health acquired Microtek, a developer of aquaculture vaccines.[13]

2010s-present

[edit]

In January 2011, Pfizer Animal Health acquired Synbiotics, a developer of immunodiagnostic tests for companion and food production animals, for $20 million.[14]

In February 2011, Pfizer acquired King Pharmaceuticals; its Alpharma subsidiary was integrated into Pfizer Animal Health.[15]

In June 2012, Pfizer Animal Health was renamed Zoetis.[16]

In February 2013, Zoetis became a public company via an initial public offering, raising $2.2 billion.[17] Most of the money raised through the IPO was used to pay off existing Pfizer debt.[2] In June 2013, Pfizer divested itself of its remaining shares in Zoetis.[18]

In February 2015, the company acquired a portfolio of pet drugs from Abbott Laboratories for approximately $255 million.[19]

In July 2015, the company acquired KL Automation, a robotics company specializing in automation technology for poultry hatchery.[20]

In November 2015, the company announced it would acquire Pharmaq, a developer of aquaculture treatments and diseases, for $765 million.[21][22]

In August 2016, the company acquired Scandinavian Micro Biodevices for $80 million.[23][24]

In April 2017, Zoetis acquired Ireland-based Nexvet, a company with a biologics focused technology and product candidate pipeline.[25]

In July 2018, the company acquired Abaxis for $1.9 billion in cash.[26][27]

In June 2022, Zoetis acquired Basepaws, a privately held genetics company.[28]

In August 2022, the company acquired Newmetrica, a Scottish company that develops digital tools designed to measure health-related quality of life.[29]

In September 2022, Zoetis acquired Jurox, which develops 150 medicines including Alfaxan.[30]

In August 2023, the company opened a 1.4 million square foot facility on 145 acres in Lincoln, Nebraska.[31]

In September 2023, Zoetis acquired Petmedix, a privately held Cambridge, UK-based company, to bring the benefits of species-specific antibody therapies to pet owners.[32][33]

In December 2023, Zoetis acquired adivo, a German manufacturer of antibodies for pet medicine.[34]

In October 2024, the company sold its medicated feed additive product portfolio and certain water-soluble products to Phibro Animal Health.[35][36]

In February 2025, the United States Department of Agriculture granted Zoetis conditional approval to deploy its bird flu vaccine in poultry,[37] after a bird flu outbreak had infected nearly 70 people in the USA, resulting in one death, with most cases occurring among farm workers exposed to infected poultry or cattle.[38][39] In January 2025, the USDA announced plans to replenish its bird flu vaccine stockpile for poultry, aligning with the strain affecting commercial and wild bird populations, similar to efforts following major outbreaks in 2014 and 2015.[40]

In November 2025, the company acquired Veterinary Pathology Group.[41]

In March 2026, the company agreed to acquired the genomics business of Neogen.[42]

In July 2026, the company agreed to acquire VitalRADS, a veterinary teleradiology platform.[43]

Products

[edit]

Zoetis' manufacturing network, includes 28 sites in 11 countries. Each facility is designed to meet chemical and infectious agent safety regulatory requirements. Many R&D operations are co-located with manufacturing sites, a collaboration that allows bringing new products to market faster.

Zoetis products include:[1]

References

[edit]
  1. 1 2 3 4 5 6 "Zoetis Inc. Form 10-K for the fiscal year ended December 31, 2025". United States Securities and Exchange Commission. 12 February 2026.
  2. 1 2 3 4 "Shares of animal health company Zoetis soar in IPO". CBS News. 1 February 2013.
  3. 1 2 3 4 5 "Form S-1". U.S. Securities and Exchange Commission. 10 August 2012.
  4. "SmithKline to Sell Its Animal Health Business : Drugs: British giant agrees to sell unit for $1.45 billion to focus on human care. Analysts hail plan". Los Angeles Times. 24 November 1994.
  5. Frank, Robert; Scott, Hensley (16 July 2002). "Pfizer to Buy Pharmacia For $60 Billion in Stock". The Wall Street Journal. ISSN 0099-9660.
  6. "What you need to know about Zoetis, Pfizer's animal health ..." MLive Media Group. 2 February 2013.
  7. "Pfizer Animal health To Buy Embrex In Deal Worth $155M". WRAL-TV. 11 December 2006.
  8. "Pfizer Animal Health to Acquire Catapult Genetics and Bovigen" (Press release). Pfizer. 18 March 2008.
  9. "Pfizer Animal Health Enters into Agreement to Acquire Animal Health Products from Schering-Plough" (Press release). Business Wire. 23 April 2008 via Pfizer.
  10. "Pfizer Inc. (JOBS) to Buy Vetnex Animal Health from ICICI Unit". Biospace. Mumbai. Reuters. 8 June 2009.
  11. "New Pfizer Animal Health is Unveiled". The Beef Site. 20 October 2009.
  12. "Pfizer and Wyeth to Divest Certain Animal Health Assets to Boehringer Ingelheim" (Press release). Business Wire. 21 September 2009 via Pfizer.
  13. "Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish" (Press release). PR Newswire. 27 May 2010 via FierceBiotech.
  14. "Pfizer Animal Health Completes Acquisition of Synbiotics Corporation" (Press release). Pfizer. 3 January 2011.
  15. "Pfizer completes acquisition of King Pharmaceuticals". MLex. 1 March 2011.
  16. "Pfizer Renames Animal Health Division Zoetis". The Poultry Site. 8 June 2012.
  17. J. DE LA MERCED, MICHAEL (1 February 2013). "Shares of Zoetis Surge on Debut". The New York Times. New York.
  18. "Pfizer Gives Up Stake in Zoetis". Yahoo Finance. 26 June 2013.
  19. "Zoetis completes $255 million acquisition of Abbott Animal ..." MLive Media Group. 11 February 2015.
  20. "Zoetis buys KL Products, boosting poultry health service". Watt Poultry. 30 July 2015.
  21. "Zoetis Inc. Form 8-K Current Report Filed 2015-11-02". Archived from the original on 23 January 2025.
  22. "Zoetis Purchasing PHARMAQ for $765M". Genetic Engineering and Biotechnology News. 3 November 2015.
  23. "Zoetis acquires Scandinavian Micro Biodevices to extend pipeline in veterinary diagnostics". Reuters. 8 August 2016.
  24. Weintraub, Arlene (10 August 2016). "How Zoetis is quietly building its presence in animal diagnostics". FiercePharma. Questex.
  25. Vinluan, Frank (13 April 2017). "Zoetis Builds on Biologics Pipeline with $85M Nexvet Acquisition". Xconomy.
  26. Mathias, Tamara (16 May 2018). D'Silva, Anil; Ravikumar, Sai Sachin (eds.). "Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 billion". Reuters.
  27. Dunn, Louise S. (1 August 2018). "Zoetis concludes $2 billion acquisition of Abaxis". Today's Veterinary Business.
  28. "Zoetis Completes Acquisition of Basepaws, an Innovative Leader in Petcare Genetics, to Strengthen its Portfolio of Precision Animal Health Solutions". Business Wire. 22 June 2022. Archived from the original on 17 March 2026.
  29. "Zoetis Inc. acquired Newmetrica Limited". S&P Global. 31 August 2022.
  30. "Zoetis Announces the Completion of its Acquisition of Jurox, a Leading Provider of Livestock and Companion Animal Products". BioSpace. 30 September 2022.
  31. "Zoetis Welcomes Officials to Open New State-of-the-Art Facility in Lincoln" (Press release). Business Wire. 9 August 2023. Archived from the original on 7 June 2026.
  32. Simon (15 September 2023). "PetMedix joins Zoetis to bring the benefits of species-specific antibody therapies to pet owners". PetMedix. Archived from the original on 26 October 2023.
  33. "Zoetis acquires PetMedix". Pet Gazette. 28 September 2023.
  34. "Clifford Chance advises Zoetis on the acquisition of adivo GmbH". Clifford Chance. 22 December 2023.
  35. "Phibro Animal Health Corporation Completes Acquisition of Zoetis' Medicated Feed Additive Product Portfolio and Certain Water-Soluble Products" (Press release). Phibro Animal Health. 31 October 2024.
  36. "Phibro Animal Health completes acquisition of Zoetis' medicated feed additives". Modern Poultry. 7 November 2024.
  37. "US gives conditional nod to Zoetis' bird flu vaccine for poultry". Reuters. Archived from the original on 17 February 2025.
  38. "H5 Bird Flu: Current Situation". Centers for Disease Control and Prevention. 14 February 2025.
  39. Bettelheim, Adriel (18 February 2025). "Updated bird flu vaccine for poultry gets license". Axios.
  40. Douglas, Leah; Polansek, Tom (8 January 2025). "US to build new stockpile of bird flu vaccine for poultry". Reuters.
  41. "Zoetis Inc. acquired Veterinary Pathology Group Limited". S&P Global. 10 November 2025.
  42. "Neogen Announces Sale of Genomics Business to Zoetis" (Press release). Neogen. 2 March 2026.
  43. Schisgall, Elias (14 July 2026). "Zoetis Agrees to Buy VitalRADS". MarketWatch.
[edit]
  • Official website
  • Business data for Zoetis: